Business ❯ Finance ❯ Stock Market ❯ Equities

Novo Nordisk

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

A fresh approval plus a $499 cash offer signals a bid to widen access, blunt copycats.

S&P 500 Gains 1% on Tesla Robotaxi Debut and Merger Speculation; Supermicro Shares Plunge